Company profile
Endlyz Therapeutics
Developing therapeutics to restore endo-lysosomal function and halt neurodegeneration in Parkinson’s & other dementias.
- Industry
- Biotechnology Research
- Employees
- 7
- Founded
- 2021
Endlyz Therapeutics company summary
Endlyz Therapeutics is a company in the Biotechnology Research industry, founded in 2021. On LinkedIn the company has around 7 employees.
What technology does Endlyz Therapeutics use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About Endlyz Therapeutics
Endlyz Therapeutics Inc. and Endlyz UK Ltd (together ‘Endlyz’) are developing disease-modifying therapeutics that restore endo-lysosomal function and abrogate neurodegeneration in Parkinson’s disease and other dementias. By leveraging extensive industry experience, a robust investor syndicate, and academic collaborations that provide access to advanced technologies on an exclusive basis, Endlyz is well positioned to lead the industry in our programmes. The company is open to discuss collaborations and in-licensing of complimentary programmes.
Compare companies similar to Endlyz Therapeutics
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
Endlyz Therapeutics endlyz.com | Biotechnology Research | 7 | 2021 | - |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about Endlyz Therapeutics
What does Endlyz Therapeutics do?
Endlyz Therapeutics Inc. and Endlyz UK Ltd (together ‘Endlyz’) are developing disease-modifying therapeutics that restore endo-lysosomal function and abrogate neurodegeneration in Parkinson’s disease and other dementias. By leveraging extensive industry experience, a robust investor syndicate, and academic collaborations that provide access to advanced technologies on an exclusive basis, Endlyz is well positioned to lead the industry in our programmes. The company is open to discuss collaborations and in-licensing of complimentary programmes.
How many employees does Endlyz Therapeutics have?
Endlyz Therapeutics has around 7 employees on LinkedIn.
When was Endlyz Therapeutics founded?
Endlyz Therapeutics was founded in 2021.
Build a lead list from companies like Endlyz Therapeutics
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.